Introduction of the concept of “safe” genotoxin exposure levels and how this benefitted patients and the pharmaceutical industry

‌Swansea-led work on “genotoxic thresholds” provided peace of mind to 25,000 patients who took anti-viral tablets (Viracept) contaminated with the genotoxin ethyl methanesuphonate (EMS). This work concurrently under-pined changes to regulatory guidelines for drug assessment with respect to low dose exposures to genotoxins. Genotoxins are the term for chemicals (and physical agents like radiation) that damage DNA, DNA damage leads to cancer and so genotoxin exposures are in general not a good thing.

之前(2008年以前), genotoxicity was assumed to be linear with respect to drug dose and genotoxic drugs were discarded. This was based on the precautionary principle as no-one really understood low dose effects. Our research on low dose exposures to carcinogenic genotoxins validated genotoxic thresholds - low level genotoxic exposures do not pose significant risks to DNA. This is now incorporated into worldwide regulatory guidelines. 的 Viracept incident (where a Roche drug was found to be contaminated with very low levels of a potent genotoxic carcinogen) tested this threshold approach. 的 European Medicines Agency (July 2008) accepted that there was no long term risk to patients who received contaminated tablets, thus providing piece of mind to the affected patients and producing a paradigm shift in relation to genotoxin exposures.‌‌‌‌

Dose response relationships for DNA damage/mutation (y axis) and dose (x axis). 的 solid line represents the linear dose response that has been widely accepted to exist, although it has been extrapolated from high doses without any low dose data. 的 dotted line represents the threshold dose response that we have proven to exist for some DNA damaging agents, by specifically looking at the low dose region. 


Contamination of Roche’s drug Viracept causes worldwide concern:

EM(E)A document with conclusions of Viracept incident with numbers of patients affected:

European Food standards Agency (EFSA) report on genotoxicity and the fact that thresholds exist, citing role of Swansea in genotoxic threshold story: http://www.欧洲食品Safety署.europa.欧盟/ en / 欧洲食品Safety署journal /酒吧/ 2379.htm

General overview of Viracept case:


  1. 帕里JM, Fielder RJ, McDonald A (1994). Guidelines for testing of chemicals: Thresholds for aneuploidy-inducing chemicals. 诱变9:503 - 504.
  2. 帕里JM, Jenkins GJS, Haddad F, Bourner R, Parry EM. (2000). In vitro and in vivo extrapolations of genotoxin exposures: consideration of factors which influence dose-response thresholds. Mutation research - genetic toxicology and environmental mutagenesis. 464:53-63.
  3. Jenkins GJS, Doak SH, Johnson GE, Quick E, Waters EM, Parry JM (2005). Do dose response thresholds exist for genotoxic alkylating agents? 诱变20:389 - 398. 
  4. Doak SH, Jenkins GJS, Johnson GE, Quick E, Parry EM, 帕里JM (2007). Mechanistic influences for mutation induction curves following exposure to DNA-reactive carcinogens. 癌症研究67:3904 - 3911. 
  5. Johnson GE, Doak SH, Griffiths SM, Quick EL, Skibinski DO, Zoulikha M Zaïr ZM, Jenkins GJ (2009). Non-linear dose–response of DNA-reactive genotoxins: Recommendations for data analysis. 突变研究678:95 - 100.
  6. 往M,詹金斯 GJ, Doak SH,辛格R, 布朗K, 通用电气和约翰逊 (2011).  N-Methylpurine DNA Glycosylase Plays a Pivotal Role in the Threshold Response of Ethyl Methanesulfonate-Induced Chromosome Damage. Toxicological Sciences 119: 346–358.